The product is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery, and the two lots were distributed to 20 states from Oct. 22, 2012 to December 14, 2012.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The two lots “may contain a strain of yeast on one or more parts in the kit and should be considered non-sterile and unsafe for use,” according to the news release. Mobius has not received any report of adverse events related to the recall, according to the release.
Mobius has begun an investigation into the cause of the possible non-sterile lots.
More Articles on Product Recalls:
FDA Class 1 Recall Issued for Fisher & Paykel Breathing Circuit
Bunnell Ventilator Patient Circuits Recalled by FDA
Class 1 Recall Issued for Ventlab’s Manual Resuscitators
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.